Search research articles
Contact Us
Filters
Showing results (41-50 of 71) with videos related to
Page
of 8
Sort By:
Virus Research
|
August 8, 2016
From clinical sample to complete genome: Comparing methods for the extraction of HIV-1 RNA for high-throughput deep sequencing
Marion Cornelissen, Astrid Gall, Monique Vink, et al.
Bone Marrow Transplantation
|
November 19, 2022
Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome unclassifiable - a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
Joanna Drozd-Sokolowska, Luuk Gras, Nienke Zinger, et al.
British Journal of Haematology
|
November 28, 2023
Early liver complications after allogeneic haematopoietic stem cell transplantation in patients with myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of the EBMT
Marie Robin, Luuk Gras, Linda Koster, et al.
Bone Marrow Transplantation
|
November 12, 2024
Satisfactory outcomes following a second autologous hematopoietic cell transplantation for multiple myeloma in poor stem cell mobilizers: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
Matjaz Sever, Joanna Drozd-Sokolowska, Luuk Gras, et al.
Bone Marrow Transplantation
|
April 1, 2022
Correction: Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT
Juan-Carlos Hernández-Boluda, Arturo Pereira, Nienke Zinger, et al.
Bone Marrow Transplantation
|
January 11, 2022
Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT
Laure Vincent, Luuk Gras, Patrice Ceballos, et al.
Bone Marrow Transplantation
|
January 23, 2022
Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT
Juan-Carlos Hernández-Boluda, Arturo Pereira, Nienke Zinger, et al.
Bone Marrow Transplantation
|
August 29, 2025
Conditioning intensity in myelodysplastic patients aged ≥ 50 years undergoing allogeneic hematopoietic cell transplantation (allo-HCT): a study on behalf of the chronic malignancies working party of the EBMT
Noureddine Henoun Loukili, Luuk Gras, Linda Koster, et al.
American Journal of Hematology
|
October 20, 2022
Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: A retrospective study by the chronic malignancies working party of the EBMT
Yves Chalandon, Giulia Sbianchi, Luuk Gras, et al.
American Journal of Hematology
|
November 28, 2024
Methotrexate Versus Mycophenolate Mofetil Prophylaxis in Allogeneic Hematopoietic Cell Transplantation for Chronic Myeloid Malignancies: A Retrospective Analysis on Behalf of the Chronic Malignancies Working Party of the EBMT
Thomas Luft, Luuk Gras, Linda Koster, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 71) with videos related to
Sort By:
Page
of 8
Virus Research
|
August 8, 2016
From clinical sample to complete genome: Comparing methods for the extraction of HIV-1 RNA for high-throughput deep sequencing
Marion Cornelissen, Astrid Gall, Monique Vink, et al.
Bone Marrow Transplantation
|
November 19, 2022
Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome unclassifiable - a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
Joanna Drozd-Sokolowska, Luuk Gras, Nienke Zinger, et al.
British Journal of Haematology
|
November 28, 2023
Early liver complications after allogeneic haematopoietic stem cell transplantation in patients with myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of the EBMT
Marie Robin, Luuk Gras, Linda Koster, et al.
Bone Marrow Transplantation
|
November 12, 2024
Satisfactory outcomes following a second autologous hematopoietic cell transplantation for multiple myeloma in poor stem cell mobilizers: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
Matjaz Sever, Joanna Drozd-Sokolowska, Luuk Gras, et al.
Bone Marrow Transplantation
|
April 1, 2022
Correction: Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT
Juan-Carlos Hernández-Boluda, Arturo Pereira, Nienke Zinger, et al.
Bone Marrow Transplantation
|
January 11, 2022
Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT
Laure Vincent, Luuk Gras, Patrice Ceballos, et al.
Bone Marrow Transplantation
|
January 23, 2022
Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT
Juan-Carlos Hernández-Boluda, Arturo Pereira, Nienke Zinger, et al.
Bone Marrow Transplantation
|
August 29, 2025
Conditioning intensity in myelodysplastic patients aged ≥ 50 years undergoing allogeneic hematopoietic cell transplantation (allo-HCT): a study on behalf of the chronic malignancies working party of the EBMT
Noureddine Henoun Loukili, Luuk Gras, Linda Koster, et al.
American Journal of Hematology
|
October 20, 2022
Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: A retrospective study by the chronic malignancies working party of the EBMT
Yves Chalandon, Giulia Sbianchi, Luuk Gras, et al.
American Journal of Hematology
|
November 28, 2024
Methotrexate Versus Mycophenolate Mofetil Prophylaxis in Allogeneic Hematopoietic Cell Transplantation for Chronic Myeloid Malignancies: A Retrospective Analysis on Behalf of the Chronic Malignancies Working Party of the EBMT
Thomas Luft, Luuk Gras, Linda Koster, et al.
Page
of 8